2017-02-010 - ELLA Stapler-02 - Endo-Luminal Linear Anastomosis - Stapler
Contacts
LT
Acronim & Gínjol codes
ELLA Stapler-02
2017-02-010
Main technology offer
The ELLA-stapler serves as a therapeutic tool in the construction of an intestinal anastomosis, specifically intracorporeal ileo-colic anastomosis after a right laparoscopic hemicolectomy
Ownership
L'Hospitalet de Llobregat, Spain
2004
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
Public Partners
Readiness Level
3-4 Experimental PoC /
5 Prototype /
6-7 MVP /
8 Industrialization /
9 Commercialization
MIN
1
2
3
4
5
6
7
8
9
10
MAX
MIN
1
2
3
4
5
6
7
8
9
10
MAX
MIN
1
2
3
4
5
6
7
8
9
10
MAX
Impact: ESG & SDG Goals
Health and Safety: new improved surgical method.
-
Market Data
Because of its technical difficulty, laparoscopic right colectomy with intra-corporeal anastomosis is performed only by a small number of laparoscopically very skilled surgeons. Current staplers do not solve this problem. Thus, there is a need of a safer and easier to be managed stapler. With the new ELLA Stapler it will be possible to perform successfully and in a standardized fashion most of ileo-colic and small bowel anastomosis which are presently performed. This new technique avoids the state of the art problems of cross-stapling and the need to close any enterotomy. The ELLA-anastomosis could be a safe, easy and standard technique. Thus, clinicians would rather work with this new device.
0
0
0
IDIBELL is seeking a company partner to further develop the technology through a co-development agreement.
Traditional types of physical wound closure (sutures, staples, clips) continue to represent the lion's share of the wound closure and related products market. The total market size of the sutures and staples worldwide market was evaluated at 4.2 Billion US dollar, growing at a CAGR of approximately 3.5%. The Surgical Stapling market was estimated at 1.5 Billion growing at a CAGR of approximately 5.5%. However the share of the sutures and staples market as part of the wound closure and related products market is expected to decline from 35% in 2012 to 32% in 2017. The market is controlled by companies like Ethicon (J&J) with 80% of the sutures, staples and mechanical closure market, followed by Covidien and B.Braun.
ELLA Stapler is a medical tool to be used in patients undergoing a laparoscopic right colectomy or undergoing any kind of laparoscopic intestinal resection and reconstruction of the intestinal integrity. This device has been conceived and designed to address the problems of intracorporeal ileo-colic anastomosis after right, extended right or subtotal colectomy. ELLA anastomosis technique could be applied to all forms of anastomoses in the small bowel anastomosis during laparoscopy. It could also be applied as a first-choice technique in the closure of a protective ileostomy/colostomy.
Funding
Development of a prototype and a MVP.
Fundings for the development of the prototype and a MVP.
Development of of a prototype
Technology Status
The invention presents a novel approach for the safe and easy performance of an otherwise very complex laparoscopic procedure. With the traditional approach, the primary laparoscopic operation for the resection of the right colon has to be completed using a large incision in order to perform an anastomosis. The presented technology would eliminate the need for this large incision, resulting in a reduction of surgical trauma and a transformation of the right-sided colectomy into a real laparoscopic procedure.
Surgical method: limited patentability
Development of a non-functional prototype with fundings, or reach a co-development agreement with an interested partner.
Additional information
New stapler is going to reduce the operating time. The ileum-colon anastomosis will specially be standardized, thus reducing the risk of postoperative complications and including improved patient results in less time